Precision Biologics Manufacturing breaks ground creating 200-300 jobs and expanding U.S.-based wound care manufacturing in 2026 HENDERSON, NV AND LAS VEGAS, NV / ACCESS Newswire / September 30, 2025 / ...
Transitioning innovative cell-based therapies from research environments to GMP-compliant manufacturing presents recurring ...
HOPEWELL, N.J., Aug. 11, 2025 /PRNewswire/ -- ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, today announced the launch of its cGMP ...
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Cellistic®, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing, announces the successful audit and GMP certification of its ...
The AAV vector market is advancing due to the rising demand for gene therapies targeting disease causes at the cellular level ...
Hopewell-based team delivers on ProBio's promise of speed, quality, and reliability—offering a transparent, fixed-cost model and ≥85% supercoiled plasmid DNA in record time for clinical programs. At ...
ProBioGen has been selected to operate the process development and GMP production facility for Advanced Therapy Medicinal Products at the Berlin Center for Gene and Cell Therapies.
NANJING, China--(BUSINESS WIRE)--GenScript ProBio announced today the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback